Fisheries and Health Notices




1144
NEW ZEALAND GAZETTE
No. 52

Fisheries

Fisheries (Satellite Vessel Monitoring) Regulations 1993

The Fisheries (Automatic Location Communicator) Notice 2000 (No. 1) (No. F150)

Pursuant to regulation 5 of the Fisheries (Satellite Vessel Monitoring) Regulations 1993, the Deputy Manager Compliance, Ministry of Fisheries, acting pursuant to delegated authority, hereby gives the following notice:

Notice

  1. Title and Commencement—(1) This notice may be cited as the Fisheries (Automatic Location Communicator) Notice 2000 (No. 1).

(2) This notice comes into effect on the day after its notification in the New Zealand Gazette.

  1. Interpretation—In this notice, “type approval” means an approval given by the Chief Executive of the Ministry of Fisheries under regulation 5 of the Fisheries (Satellite Vessel Monitoring) Regulations 1993.

  2. Grant of type approval—Pursuant to regulation 5 (3) of the Fisheries (Satellite Vessel Monitoring) Regulations 1993, a provisional type approval has been granted to the following Inmarsat-C device to 30 September 2001:

    Product Name: Thrane & Thrane Inmarsat-C Mobile Earth Station transceiver
    Manufacturer: Thrane & Thrane A/S Denmark
    Model No.: TT3022D
    Software Version No.: Capsat Version 3.24 Non-SOLAS Fishery, which is comprised of the following:
    DTE Version: Capsat Version 3.24 (Jun 18 1999)
    DTE Forms: MAF FORMS
    DCE Version: Capsat Version 3.03 (97-11-01)

Dated at Wellington this 16th day of May 2000.

D. J. WOOD, Deputy Manager Compliance (in exercise of delegated authority).

go3578

Health

Health and Disability Services Act 1993

Ministerial Direction Under Section 25 of the Health and Disability Services Act 1993

Following consultation with the Health Funding Authority over the period 4 April 2000 to 5 May 2000, I, Annette King, direct the Health Funding Authority, under section 25 of the Health and Disability Services Act 1993, to fund beta-interferon for the treatment of multiple sclerosis.

Access to beta-interferon will be provided on the basis of the entry and stopping criteria, budgetary arrangements, and other conditions agreed from time to time in writing between the Minister of Health and the Health Funding Authority.

I consequently revoke my earlier direction, under section 25, relating to beta-interferon, dated the 17th December 1999.

Dated at Wellington this 5th day of May 2000.

ANNETTE KING, Minister of Health.

go3555

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the schedule hereto:

Schedule

Product: Cetrotide
Active Ingredient(s): Cetrorelix acetate 0.26mg equivalent to 0.25 mg cetrorelix base
Dosage Form: Injection with diluent
New Zealand Sponsor: Asta Medica Australasia Pty Limited
Manufacturer(s): Asta Medica AG, Halle-Kunsebeck, Germany

Product: Cetrotide
Active Ingredient(s): Cetrorelix acetate 3.12mg equivalent to 3.00 mg cetrorelix base
Dosage Form: Injection with diluent
New Zealand Sponsor: Asta Medica Australasia Pty Limited
Manufacturer(s): Asta Medica AG, Halle-Kunsebeck, Germany



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2000, No 52


Gazette.govt.nz PDF NZ Gazette 2000, No 52





✨ LLM interpretation of page content

🌾 Fisheries (Automatic Location Communicator) Notice 2000 (No. 1)

🌾 Primary Industries & Resources
16 May 2000
Fisheries, Satellite Vessel Monitoring, Inmarsat-C device, Type approval
  • D. J. Wood, Deputy Manager Compliance (in exercise of delegated authority)

🏥 Ministerial Direction Under Section 25 of the Health and Disability Services Act 1993

🏥 Health & Social Welfare
5 May 2000
Health, Multiple sclerosis, Beta-interferon, Funding
  • Annette King, Minister of Health

🏥 Consent to the Distribution of a New Medicine

🏥 Health & Social Welfare
Medicines, Cetrotide, Cetrorelix acetate, Asta Medica
  • Minister of Health